ERBB2 and breast cancer: As with all cancer types, biomarkers with prognostic and/or predictive power are essential tools in the clinical management of this disease, with the oestrogen receptor ⍺ (ER) and the human epidermal growth factor 2 receptor (HER2) being the foremost biomarkers in BC.